A novel DNA methylation-based surrogate biomarker for chronic systemic inflammation (Inflammation Latent Variable Methylation Surrogate, InfLaMeS)
- 24 September 2025
- journal article
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 80 (12)
Abstract
Chronic low-grade systemic inflammation is a risk factor for chronic diseases and mortality and is an important biomarker in health research. DNA methylation (DNAm) surrogate biomarkers are valuable exposure, risk factor, and health outcome predictors in studies where the measures cannot be measured directly and often perform as well or better than direct measures. We generated a DNAm surrogate biomarker for chronic, systemic inflammation from a systemic inflammation latent variable of 7 inflammatory markers and evaluated its performance relative to measured inflammatory biomarkers in predicting several age-associated outcomes of interest, including mortality, activities of daily living, and multimorbidity in the Health and Retirement Study (HRS). The DNAm surrogate, Inflammation Latent Variable Methylation Surrogate (InfLaMeS), correlated with 7 individual inflammation markers (r = −0.2-0.6) and had similar or stronger associations with multimorbidity, disability, and 4-year mortality in HRS compared to the systemic inflammation latent variable measure when predicting multimorbidity, disability, and 4-year mortality in HRS. Findings were validated in an external cohort, the Irish Longitudinal Study of Ageing. These results suggest that InfLaMeS provides a robust alternative to measured blood-chemistry measures of inflammation with broad research applicability in instances where values of inflammatory markers are not measured but DNAm data are available.Keywords
Funding Information
- National Institute on Aging of the National Institutes of Health (U01AG073289, R01AG068937, R01AG060110, R01AG071071)
This publication has 47 references indexed in Scilit:
- Developing a DNAm Surrogate to Predict Cognitive Functioning among Older AdultsAlzheimer's & Dementia, 2023
- Salivary Epigenetic Measures of Body Mass Index and Social Determinants of Health Across Childhood and AdolescenceJAMA Pediatrics, 2023
- Systemic inflammation and biological aging in the Health and Retirement StudyGeroScience, 2023
- The relationship between the mode of presentation, CT‐derived body composition, systemic inflammatory grade and survival in colon cancerJournal of Cachexia, Sarcopenia and Muscle, 2022
- Epigenetic clock: A promising biomarker and practical tool in agingAgeing Research Reviews, 2022
- High-sensitivity C-reactive protein and all-cause mortality in four diverse populations: The CRONICAS Cohort StudyAnnals of Epidemiology, 2021
- A systematic review of biological, social and environmental factors associated with epigenetic clock accelerationAgeing Research Reviews, 2021
- Circulating interleukin-6 levels and cardiovascular and all-cause mortality in the elderly population: A meta-analysisArchives of Gerontology and Geriatrics, 2017
- Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysisAtherosclerosis, 2017
- Inflammation and Stroke: An OverviewNeurotherapeutics, 2016